Related Experiment Videos
Percutaneous transluminal coronary angioplasty: an expanding role in complex coronary artery disease
B Lucenta1, H G Hanley, D Fadely
1LSU School of Medicine, Shreveport.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) is increasingly used for complex coronary artery disease, offering an alternative to bypass surgery. Ongoing research aims to overcome limitations like acute closure and restenosis, and to compare PTCA effectiveness against bypass grafting.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) has evolved significantly since 1977.
- PTCA is now a primary treatment for complex single and multivessel coronary artery disease.
- It offers an alternative to coronary artery bypass grafting for many patients.
Purpose of the Study:
- To review the current role and limitations of PTCA.
- To highlight ongoing research addressing PTCA complications.
- To compare PTCA with coronary artery bypass grafting.
Main Methods:
- Review of current interventional cardiology practices.
- Summary of ongoing clinical studies involving lasers, stents, and pharmacologic agents.
- Analysis of comparative studies between PTCA and coronary artery bypass grafting.
Main Results:
- PTCA is effective for complex coronary artery disease, expanding treatment options.
- Acute closure and restenosis remain significant challenges.
- Emerging technologies and therapies show promise in mitigating PTCA complications.
Conclusions:
- PTCA is a valuable tool in managing complex coronary artery disease.
- Further research is essential to improve PTCA outcomes and define its optimal role.
- Comparative studies are crucial for guiding treatment decisions between PTCA and bypass grafting.
Abstract:
Since its inception in 1977, percutaneous transluminal coronary angioplasty (PTCA) has played an increasing role in the treatment of complex single and multivessel coronary artery disease. Many patients, previously treatable only by coronary artery bypass grafting, are now successfully treated with PTCA in the cardiac catheterization laboratory. Two important limitations to the procedure, acute closure and restenosis of the dilated vessels, persist. However, studies with lasers, intracoronary stents, perfusion catheters, thrombolysis, and antiplatelet drugs are ongoing in an attempt to minimize these complications. In addition, studies are now ongoing comparing PTCA with bypass grafting to further define the role of each in coronary disease.